All other professional, scientific and technical activities n.e.c.
FLEXIPHARMA AS
Revenue 2024
NOK 217,000
Operating profit
NOK 98,000
Equity
NOK 471,000
Incorporated
2013
Share capital
NOK 100,000
Key figures · 2024
Current ratio
19.01
Equity ratio
51.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 44.9% | |
| Net margin (%%) | 13.6% | |
| Return on assets (%%) | 10.6% | |
| Likviditet | ||
| Current ratio | 19.01 | |
| Working capital | 871k | |
| Soliditet | ||
| Equity ratio (%%) | 51.2% | |
| Debt-to-equity ratio | 0.95 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.